Vaccination with a CDR2 BV6S2/6S5 peptide in adjuvant induces peptide-specific T-cell responses in patients with multiple sclerosis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Vaccination with a CDR2 BV6S2/6S5 peptide in adjuvant induces peptide-specific T-cell responses in patients with multiple sclerosis

Published:2001 Issue:3 Volume:64 Page:298-301
ISSN:0360-4012
Container-title:Journal of Neuroscience Research
language:en
Short-container-title:J. Neurosci. Res.

Author:

Morgan Elizabeth E.,Nardo Christopher J.,Diveley Jocelyn P.,Kunin Joel,Bartholomew Richard M.,Moss Ronald B.,Carlo Dennis J.

Publisher

Wiley

Subject

Cellular and Molecular Neuroscience

Reference11 articles.

1. Results of a phase I clinical trial of a T-cell receptor vaccine in patients with multiple sclerosis. II. Comparative analysis of TCR utilization in CSF T-cell populations before and after vaccination with a TCRVβ6 CDR2 peptide

2. Vaccination Against Experimental Allergic Encephalomyelitis with T Cell Receptor Peptides

3. Preferential T-cell receptor beta-chain variable gene use in myelin basic protein-reactive T-cell clones from patients with multiple sclerosis.

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent advances in the development of vaccines for chronic inflammatory autoimmune diseases;Vaccine;2018-05

2. T cell receptor assessment in autoimmune disease requires access to the most adjacent immunologically active organ;Journal of Autoimmunity;2017-07

3. Saikosaponin a inhibits the proliferation and activation of T cells through cell cycle arrest and induction of apoptosis;International Immunopharmacology;2009-07

4. Dissection of the role of paeoniflorin in the traditional Chinese medicinal formula Si-Ni-San against contact dermatitis in mice;Life Sciences;2009-03

5. Novel therapeutic strategies for multiple sclerosis — a multifaceted adversary;Nature Reviews Drug Discovery;2008-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3